Cell Source Inc CLCS
Trading Information
- Previous Close Price
- $0.47
- Day Range
- $0.50–0.50
- 52-Week Range
- $0.25–2.25
- Bid/Ask
- $0.40 / $0.55
- Shares Outstanding
- 67.95M
- Market Cap
- $33.89M
- Volume/Avg
- 250 / 3,499
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Cell Source Inc is a biotechnology company focused on developing cell therapy treatments focused on immunotherapy. The company is involved with the development of proprietary immune system management technology. The company's subsidiary commercializes a suite of inventions relating to certain cancer treatments. The other products include Anti-rejection Veto Cell tolerance therapy for both matched and mismatched allogeneic bone marrow transplantations and Anti-rejection Veto Cell tolerance therapy for both matched as well as mismatched organ transplantation.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 0
- Website
- https://www.cell-source.com
Valuation
|
Metric
|
CLCS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CLCS
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.02 |
Interest Coverage | −3.15 |
Quick Ratio
CLCS
Profitability
|
Metric
|
CLCS
|
|---|---|
Return on Assets (Normalized) | −1,843.24% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
CLCS
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|<!gWT!l | LOCK|tW@@Q | $127B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|l$zdRMZ | LOCK|m%>K? | $76B | |||
| Moderna Inc
MRNA
| LOCK|^ps#SQ | LOCK|^G& | $75B | |||
| argenx SE ADR
ARGX
| LOCK|R$#&zF | LOCK|R# | $59B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|ZzrR@^ | LOCK|?V> | $43B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|tp?!#G | LOCK|@m@q | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|T?yy$nJT | LOCK|DmV@Y | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|G!p#^V^ | LOCK|d% | $24B | |||
| Incyte Corp
INCY
| LOCK|?&b#G%@ | LOCK|dW | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|!TN&&$Z | LOCK|p&y | $15B |
United States